3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
11
Lung Neoplasms
9
Leukemia, Myeloid, Acute
9
Wilms Tumor
8
Osteosarcoma
8
Neuroblastoma
8
Neoplasm Metastasis
8
Multiple Myeloma
8
Glioma
8
Sarcoma
7
Rhabdoid Tumor
7
Lymphoma, Non-Hodgkin
7
Hepatoblastoma
7
Carcinoma, Hepatocellular
7
Breast Neoplasms
7
Rhabdomyosarcoma
6
Neuroectodermal Tumors, Primitive, Peripheral
6
Myelodysplastic Syndromes
6
Medulloblastoma
6
Lymphoma
6
Histiocytosis, Langerhans-Cell
6
Ependymoma
6
Colorectal Neoplasms
6
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Central Nervous System Neoplasms
5
Carcinoma, Non-Small-Cell Lung
5
Sarcoma, Ewing
4
Ovarian Neoplasms
4
Melanoma
4
Endometrial Neoplasms
4
Interventions
pembrolizumab
2
durvalumab
2
Paclitaxel
2
Nivolumab
2
Ipilimumab
2
Doxorubicin
2
zanidatamab
1
veliparib
1
tucatinib
1
trilaciclib
1
trebananib
1
trastuzumab duocarmazine
1
talazoparib
1
spartalizumab
1
selinexor
1
sarilumab
1
pexidartinib
1
pertuzumab
1
pazopanib
1
patritumab
1
olaparib
1
niraparib
1
neratinib
1
ganitumab
1
dostarlimab
1
cemiplimab
1
balstilimab
1
abemaciclib
1
Trastuzumab
1
Standard of Care
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Hemangiosarcoma
×
X-Rays
×
90 days
×
Clear all
No trials found.